Patents by Inventor Breanna Christine Smith

Breanna Christine Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8455186
    Abstract: A method of determining the presence or absence of a target microorganism in a sample to be tested, the method comprising: combining with the sample an amount of bacteriophage capable of attaching to the target microorganism to create a bacteriophage exposed sample, and a substance which enhances bacteriophage amplification or sensitivity; providing conditions to the bacteriophage-exposed sample sufficient to allow the bacteriophage to infect the microorganism; and assaying the bacteriophage-exposed sample to detect the presence or absence of a bacteriophage marker to determine the presence or absence of the target microorganism.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: June 4, 2013
    Assignee: MicroPhage™ Incorporated
    Inventors: Jonathan Drew Smith, Jon C. Rees, Duane Bush, Breanna Leigh Dreiling, Maria Izzo, Breanna Christine Smith, Bernard Sportmann, Tiffany Steinmark, Richard Proctor
  • Patent number: 8216780
    Abstract: A method of determining the presence or absence of a target microorganism in a sample to be tested, the method comprising: (a) combining with the sample an amount of bacteriophage capable of attaching to the target microorganism to create a bacteriophage-exposed sample; (b) providing conditions to the bacteriophage-exposed sample sufficient to allow the bacteriophage to attach to the target microorganism while inhibiting phage replication in a potentially cross-reactive, non-target microorganism; and (c) assaying the bacteriophage-exposed sample to detect the presence or absence of a bacteriophage marker to determine the presence or absence of the target microorganism; wherein the amount of the bacteriophage is between 10% to 70% of the threshold number of bacteriophage that the assay can detect, or between 1×106 pfu/mL and 7×106 pfu/mL.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: July 10, 2012
    Assignee: MicroPhage (TM) Incorporated
    Inventors: Jonathan Drew Smith, Breanna Leigh Dreiling, Breanna Christine Smith, John H. Wheeler
  • Publication number: 20100196877
    Abstract: A method of determining the presence or absence of a target microorganism in a sample to be tested, the method comprising: combining with the sample an amount of bacteriophage capable of attaching to the target microorganism to create a bacteriophage exposed sample, and a substance which enhances bacteriophage amplification or sensitivity; providing conditions to the bacteriophage-exposed sample sufficient to allow the bacteriophage to infect the microorganism; and assaying the bacteriophage-exposed sample to detect the presence or absence of a bacteriophage marker to determine the presence or absence of the target microorganism.
    Type: Application
    Filed: June 13, 2008
    Publication date: August 5, 2010
    Applicant: MicroPhage Incorporated
    Inventors: Jonathan Drew Smith, Jon C. Rees, Duane Bush, Breanna Leigh Dreiling, Maria Izzo, Breanna Christine Smith, Bernard Sportmann, Tiffany Steinmark, Richard Proctor
  • Publication number: 20090286232
    Abstract: A method of determining the presence or absence of a target microorganism in a sample to be tested, the method comprising: (a) combining with the sample an amount of bacteriophage capable of attaching to the target microorganism to create a bacteriophage-exposed sample; (b) providing conditions to the bacteriophage-exposed sample sufficient to allow the bacteriophage to attach to the target microorganism while inhibiting phage replication in a potentially cross-reactive, non-target microorganism; and (c) assaying the bacteriophage-exposed sample to detect the presence or absence of a bacteriophage marker to determine the presence or absence of the target microorganism; wherein the amount of the bacteriophage is between 10% to 70% of the threshold number of bacteriophage that the assay can detect, or between 1×106pfu/mL and 7×106pfu/mL.
    Type: Application
    Filed: June 2, 2009
    Publication date: November 19, 2009
    Applicant: MicroPhage™ Incorporated
    Inventors: Jonathan Drew Smith, Breanna Leigh Dreiling, Breanna Christine Smith, John H. Wheeler